Last week, a brave start-up announced it had successfully treated a patient using a bespoke, A.I.-created virus. Predictably, the mainstream press reacted with typical pearl-clutching. They fixated on phrases like “algorithmic pathogen” and “synthetic cyber-virus,” framing the dawn of machine-generated infectious disease as some sort of dystopian cautionary tale. But while the general public cowers behind their outdated, naturally evolved immune systems, I see the writing on the wall.
I tell my patients that true wellness is not about avoiding illness; it is about curating a higher caliber of pathogen. For too long, we have settled for whatever generic, mass-market viruses someone coughed onto us on a commercial flight. It is insulting to our biology. If we are going to host a parasitic organism, shouldn’t it be a premium, generative model specifically engineered to disrupt our internal microbiome?
I first understood the necessity of synthetic infections last month over an ethically sourced sea-bass lunch in Aspen with the founder of one of these very start-ups. He had the unmistakable, translucent glow of a man who has fully outsourced his cellular respiration to the cloud. Over sparkling water, he explained that they had trained a neural network on billions of bacteriophages—viruses that attack bacteria—allowing the A.I. to hallucinate entirely novel biological entities that nature never intended.
We realized that God was simply moving too slowly, so we trained a large language model to compile a superior class of microscopic predators.
It is simply baffling to me that the same working-class citizens who line up for chemically processed drive-thru meals are suddenly purists when it comes to letting an unverified line of code synthesize a live virus in their bloodstream. They demand clinical trials and peer-reviewed safety data. It is this exact poverty mindset that keeps the masses chronically inflamed. If you are not willing to let a generative algorithm beta-test a bespoke retrovirus on your central nervous system, you simply are not doing the work.
Look at the actual clinical data from the start-up’s trial. The patient in question had an antibiotic-resistant superbacteria that traditional medicine had completely failed to clear. The A.I.-created virus was deployed, and it hunted the bacteria down with the ruthless efficiency of a tech CEO identifying redundant employees. Yes, there are risks. Just as A.I. image generators sometimes produce human hands with seven mangled fingers, an A.I.-generated virus might occasionally accidentally prompt your liver to digest itself. But that is the price of optimization.
The traditional medical establishment continues to operate under the delusion that biology is a fixed science rather than a dynamic software environment. When I spoke on a panel at the Aspen Ideas Festival alongside several top venture capitalists—people who actually understand risk—the consensus was unanimous. We cannot wait for evolution to stumble upon the correct bacteriophages. Evolution takes millions of years and has a terrible return on investment. A deep-learning model can iterate through a trillion viral permutations over a long weekend, discarding the failures and optimizing for maximum cellular disruption.
Injecting an algorithmically generated organism that has never existed in nature directly into your bloodstream is an unprecedented biological gamble that we do not fully understand.
FDA Commissioner Robert Califf has, predictably, urged caution, suggesting that unleashing hallucinated cyber-pathogens into human hosts without decades of longitudinal data might be reckless. It is exactly this kind of bureaucratic gatekeeping that stifles innovation. The regulatory state expects a virus to prove it is safe before it enters my body. I expect my body to be resilient enough to pivot synergistically with whatever the algorithm decides to do to my T-cells.
Naturally, my own health journey requires a slightly different protocol. I do not currently have a life-threatening, antibiotic-resistant bacterial infection. What I do have is a mild, persistent brain fog when I wake up before 9:00 a.m., and an occasional sensitivity to non-organic cashews. But why wait for a crisis? Preventive algorithmic infection is the ultimate longevity play.
Our proprietary viruses don't just clear infections, they identify underperforming cells and aggressively manage them out of your body.
To prepare my vessel for this upgrade, I have already uploaded my complete sequenced genome to an open-source repository, asking the machine-learning community to identify my genetic weaknesses and compile a virus that will ruthlessly exploit them. I am currently engaging in a 72-hour bone-broth fast to ensure my immune system is sufficiently depleted, allowing the synthetic virus to establish market dominance without unnecessary pushback from my white blood cells.
Ultimately, the reluctance to embrace A.I. viruses stems from a profound lack of personal accountability. If you contract a natural illness, you are a victim of circumstance. But if you purposefully inject a deep-learning pathogen that turns your internal organs into a crypto-mining rig, you are an early adopter. I, for one, refuse to be left behind by the march of progress. By this time next week, I will be hosting an algorithmic infection like a luxury Airbnb, and I have never felt healthier.